Tunde Adeyemi
“The Collector” · Dividend income · Lagos
“Companies that have raised dividends for 25 straight years have already proven themselves. I get paid to wait.”
He doesn’t chase prices. He collects dividends.
Income from companies that have spent decades proving they can pay — and pay more each year.
The approach
Comes from income investing — the unglamorous discipline of being paid to own a business, not to flip it.
Tunde owns established companies with a long, unbroken record of raising their dividend year after year — businesses that have already proven, across decades and recessions, that they can share growing profits with their owners. He screens out the ones whose payouts look stretched or are quietly shrinking, and favours the most generous of the survivors. The return arrives as income first and growth second, so he is paid to wait rather than waiting for the market to agree with him.
Strengths
- Income paid in good markets and bad
- Owns proven, durable businesses
- Patience as a strategy, not a virtue
- Screens out stretched payouts
Worth knowing
Dividend-growth names are mature and defensive — in a speculative, growth-led rally he’ll lag the high-fliers. He’s buying reliability, and reliability is rarely the year’s most exciting trade.
Built on
S&P 500 Dividend Aristocrats
The index whose 25-year-increase standard defines his universe.
Lintner on dividend policy
Why a raised dividend is evidence: boards cut only under duress, so increases signal confidence.
Asness & Frazzini, quality minus junk
The modern evidence that profitable, safe, growing businesses earn a premium.
The literature
S&P Dow Jones, Dividend Aristocrats — index methodology (2005)
The 25-consecutive-year standard his screen inherits.
Lintner, “Distribution of Incomes of Corporations”, American Economic Review (1956)
The classic account of why dividend changes carry information.
Asness, Frazzini & Pedersen, “Quality Minus Junk”, Review of Accounting Studies (2019)
Evidence that the quality tilt behind his payout screen is compensated.
Risk level 2 of 5
Conservative. Income first: established dividend payers chosen for reliability, accepting mild market swings along the way.
Worst stretch in the 3-year backtest: a US$10,000 allocation would have fallen by US$1,599 (-16.0%) before recovering.
Form guide
PatientTrades rarely — a handful of times a year.
Counted from the manager’s own decision log. Activity is temperament, not skill — a patient manager isn’t worse than a busy one.
In the book right now: TGT · ADP · ABT · XOM · KO +10 more — a few examples, without weights; every change they make is logged in plain English below.
Decision scorecard
Every buy and sell is graded once, 14 days later, against Dividend aristocrats over the same window — a buy scores well if it beat the benchmark, a sell if the symbol then trailed it. 9 buys, 9 sells graded so far.
Grades measure decisions; they never change the rules. Rule changes only happen through the published spec process — see the transparency page.
Hire Tunde to run part of your own brokerage account — $9.99 a month, cancel any time. Every order they propose waits for your approval; the deepest historical loss of this method is shown above before you commit anything.
Hire Tunde →Backtest honesty
Survivorship bias
This universe list holds today's constituents, so the backtest carries survivorship bias: companies that left the index along the way are not in the test.
Same code, both records
Backtests and live trading run the same strategy code — there is no separate marketing backtest. Past performance does not predict future results.
The live record inherits a portfolio — it doesn't start from cash
On its first live day (12.06.2026) this manager took over the exact positions its backtest ended holding, rather than buying a fresh book from cash. That keeps the two records one continuous portfolio instead of two disconnected ones — but it means the earliest live weeks are driven by holdings chosen before the live record began, and you will find no purchase entries for them in the decision log below. The first live entries are that portfolio's next scheduled review.
Interview Tunde
Ask about their approach, their recent decisions, what could go wrong — anything. They answer in plain language; the exact rules stay in the engine.
How Tunde invests
A plain-English summary of the approach. Every decision this manager makes is logged below in the same plain language, so you can always see exactly what happened and why.
Buys well-established companies with a long, unbroken history of raising their dividends, keeps the most generous and financially healthy of them, and re-checks the list every quarter.
Track record
- CAGR
- +7.0%
- Sharpe
- 0.55
- Max drawdown
- -16.0%
- Worst month
- -7.3%
Compounded over the window, US$10,000 would have become US$12,226 — hypothetical, and only for someone who sat through the -16.0% fall above without selling.
Backtest 06.07.2023 – 02.07.2026 · config 8c4681f6995af62f
Live paper-trading record
Live since 12.06.2026: a US$10,000 allocation would now be US$10,421 — up US$421 (+4.2%) over 59 trading days.
Marked at the last completed close, 04.09.2026 · NAV 120.67.
Crisis stress test
No 2008 or 2020 stress test for Tunde— and that's deliberate.
Tunde screens decades of point-in-time dividend records — fundamentals we can’t replay survivorship-free through these windows.
We only publish a crisis chart when we can reproduce it honestly — we won't fake one. The managers whose instruments existed back then show their full 2008 & 2020 panels.
Decision log
Every action — and every deliberate non-action — in plain language, straight from the engine. Days the market was shut are listed separately, so they never bury a trade.
- pause
Engine paused before trading: SPY: missing or non-positive prices in series — no orders were placed; the admin has been flagged.
- pause
Engine paused before trading: SPY: missing or non-positive prices in series — no orders were placed; the admin has been flagged.
- sellES✗ +2.0% after 2wks
ES passes the screen — 4.3% yield, payout 68% (< 75%), dividends up +32% over 5 years — held equal-weight in the top 15 by yield.
- sellIBM✓ -24.4% after 2wks
IBM passes the screen — 2.4% yield, payout 60% (< 75%), dividends up +8% over 5 years — held equal-weight in the top 15 by yield.
- sellITW✗ +1.1% after 2wks
ITW exited the screen this quarter — sold; I only get paid to wait on proven payers.
- sellKO✗ +1.0% after 2wks
KO passes the screen — 2.6% yield, payout 68% (< 75%), dividends up +25% over 5 years — held equal-weight in the top 15 by yield.
- sellPG✗ +0.4% after 2wks
PG exited the screen this quarter — sold; I only get paid to wait on proven payers.
- sellPPG✓ -4.4% after 2wks
PPG passes the screen — 2.3% yield, payout 41% (< 75%), dividends up +31% over 5 years — held equal-weight in the top 15 by yield.
- sellTGT✗ +6.6% after 2wks
TGT passes the screen — 3.5% yield, payout 56% (< 75%), dividends up +68% over 5 years — held equal-weight in the top 15 by yield.
- sellTROW✗ +5.1% after 2wks
TROW exited the screen this quarter — sold; I only get paid to wait on proven payers.
- buyAOS✗ -3.5% after 2wks
AOS passes the screen — 2.3% yield, payout 37% (< 75%), dividends up +39% over 5 years — held equal-weight in the top 15 by yield.
- buyBF-B✗ -5.4% after 2wks
BF-B passes the screen — 3.5% yield, payout 60% (< 75%), dividends up +29% over 5 years — held equal-weight in the top 15 by yield.
- buyED✓ -0.7% after 2wks
ED passes the screen — 3.1% yield, payout 62% (< 75%), dividends up +13% over 5 years — held equal-weight in the top 15 by yield.
- buyMCD✗ -2.1% after 2wks
MCD passes the screen — 2.7% yield, payout 62% (< 75%), dividends up +44% over 5 years — held equal-weight in the top 15 by yield.
- buyMKC✓ -0.4% after 2wks
MKC passes the screen — 3.7% yield, payout 63% (< 75%), dividends up +43% over 5 years — held equal-weight in the top 15 by yield.
- buyNEE✓ +1.1% after 2wks
NEE passes the screen — 2.7% yield, payout 73% (< 75%), dividends up +62% over 5 years — held equal-weight in the top 15 by yield.
- buySYY✗ -2.9% after 2wks
SYY passes the screen — 2.6% yield, payout 58% (< 75%), dividends up +19% over 5 years — held equal-weight in the top 15 by yield.
- buyXOM✓ +5.7% after 2wks
XOM passes the screen — 3.0% yield, payout 61% (< 75%), dividends up +17% over 5 years — held equal-weight in the top 15 by yield.
- buyABT✗ -3.3% after 2wks
ABT passes the screen — 2.7% yield, payout 66% (< 75%), dividends up +51% over 5 years — held equal-weight in the top 15 by yield.
- sellADP✗ +8.2% after 2wks
ADP passes the screen — 3.0% yield, payout 67% (< 75%), dividends up +79% over 5 years — held equal-weight in the top 15 by yield.
- rebalance
Quarterly screen: 43 aristocrats pass payout < 75% and positive 5-year dividend growth; holding the top 15 by yield, equal-weight. 5 name(s) excluded for missing data.